Radical Prostatectomy clinical trials at University of California Health
1 research study open to eligible people
Pivotal Study of Voro Urologic Scaffold
open to eligible males ages 45 years and up
The objective of this study is to compare safety and effectiveness of the Voro Urologic Scaffold in adult men undergoing robotic assisted radical prostatectomy as compared to control arm. The study is a multi-center, single blind, randomized, controlled trial. Up to 266 participants will be treated at up to 30 centers in the United States. The study will consist of a Baseline visit, implantation during robotic assisted radical prostatectomy (RARP), catheter removal, 6 weeks, 6 months, 12 months, 18 months, and 24 months.
at UCLA UCSD
Our lead scientists for Radical Prostatectomy research studies include Michael Liss, MD Wayne Brisbane, MD.
Last updated: